Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA-Binding Protein EWS | 11 | 2024 | 210 | 2.260 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 104 | 1.840 |
Why?
|
Oncogene Proteins, Fusion | 14 | 2024 | 1606 | 1.550 |
Why?
|
Wilms Tumor | 7 | 2024 | 379 | 1.180 |
Why?
|
Chromatin | 13 | 2024 | 2960 | 1.160 |
Why?
|
In Situ Hybridization | 12 | 2021 | 1900 | 0.890 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2024 | 8545 | 0.820 |
Why?
|
Bone Neoplasms | 6 | 2021 | 2529 | 0.740 |
Why?
|
Tumor Suppressor Proteins | 10 | 2016 | 2803 | 0.730 |
Why?
|
Karyopherins | 2 | 2024 | 132 | 0.700 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 785 | 0.640 |
Why?
|
Odontogenic Tumors | 3 | 2024 | 45 | 0.570 |
Why?
|
Calmodulin-Binding Proteins | 2 | 2019 | 233 | 0.570 |
Why?
|
Gene Silencing | 2 | 2018 | 1509 | 0.570 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.560 |
Why?
|
Enhancer Elements, Genetic | 3 | 2018 | 1363 | 0.550 |
Why?
|
Genes, Wilms Tumor | 2 | 2007 | 92 | 0.530 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2020 | 633 | 0.530 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 857 | 0.530 |
Why?
|
WT1 Proteins | 4 | 2024 | 184 | 0.530 |
Why?
|
Medulloblastoma | 2 | 2019 | 678 | 0.500 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2021 | 217 | 0.490 |
Why?
|
Salivary Gland Neoplasms | 3 | 2024 | 304 | 0.470 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1897 | 0.470 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1266 | 0.470 |
Why?
|
Myocardial Contraction | 1 | 2019 | 1517 | 0.470 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.430 |
Why?
|
Sirtuins | 3 | 2022 | 320 | 0.420 |
Why?
|
DNA | 5 | 2023 | 7219 | 0.420 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 100 | 0.420 |
Why?
|
Sarcoma, Clear Cell | 2 | 2024 | 72 | 0.420 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3428 | 0.410 |
Why?
|
Cell Line, Tumor | 27 | 2024 | 16979 | 0.410 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 586 | 0.390 |
Why?
|
Adaptor Proteins, Signal Transducing | 9 | 2015 | 2898 | 0.390 |
Why?
|
Transcription, Genetic | 6 | 2022 | 7595 | 0.370 |
Why?
|
Myocardium | 3 | 2019 | 4725 | 0.360 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2024 | 435 | 0.340 |
Why?
|
Sarcoma, Synovial | 2 | 2021 | 153 | 0.330 |
Why?
|
Chromosomes, Human, X | 2 | 2007 | 321 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2110 | 0.290 |
Why?
|
Kidney Neoplasms | 5 | 2024 | 4248 | 0.290 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3879 | 0.270 |
Why?
|
Protein Isoforms | 4 | 2024 | 1699 | 0.270 |
Why?
|
Mesenchymal Stem Cells | 4 | 2018 | 1642 | 0.250 |
Why?
|
Wnt Proteins | 3 | 2016 | 718 | 0.250 |
Why?
|
Spheroids, Cellular | 2 | 2024 | 330 | 0.240 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 422 | 0.240 |
Why?
|
Transcription Factors | 9 | 2022 | 12125 | 0.240 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.240 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9418 | 0.230 |
Why?
|
Antigens, Nuclear | 2 | 2015 | 184 | 0.230 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 286 | 0.230 |
Why?
|
Liver Neoplasms | 3 | 2015 | 4320 | 0.230 |
Why?
|
Neoplastic Stem Cells | 4 | 2017 | 1347 | 0.230 |
Why?
|
Sequence Analysis, RNA | 6 | 2017 | 2020 | 0.220 |
Why?
|
Gene Deletion | 5 | 2018 | 2667 | 0.210 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1964 | 0.210 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1118 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1159 | 0.210 |
Why?
|
Cyclin D1 | 1 | 2024 | 451 | 0.200 |
Why?
|
Hydrazines | 1 | 2024 | 224 | 0.200 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 225 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.190 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 89 | 0.190 |
Why?
|
RNA, Untranslated | 2 | 2018 | 459 | 0.190 |
Why?
|
Adenocarcinoma | 5 | 2020 | 6339 | 0.190 |
Why?
|
Single-Cell Analysis | 5 | 2021 | 2449 | 0.190 |
Why?
|
Salivary Glands | 2 | 2021 | 229 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2023 | 2824 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1135 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 705 | 0.180 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3798 | 0.180 |
Why?
|
Kidney | 5 | 2010 | 7049 | 0.180 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5794 | 0.170 |
Why?
|
RNA, Viral | 2 | 2021 | 2846 | 0.170 |
Why?
|
Fibrillar Collagens | 1 | 2019 | 42 | 0.170 |
Why?
|
Animals | 36 | 2024 | 168441 | 0.170 |
Why?
|
Humans | 79 | 2024 | 761423 | 0.160 |
Why?
|
Cysteine | 1 | 2024 | 892 | 0.160 |
Why?
|
Mice | 29 | 2024 | 81509 | 0.160 |
Why?
|
DNA-Binding Proteins | 6 | 2022 | 9606 | 0.160 |
Why?
|
Aniline Compounds | 2 | 2015 | 1069 | 0.160 |
Why?
|
Jaw Neoplasms | 1 | 2019 | 70 | 0.160 |
Why?
|
Cell Survival | 4 | 2017 | 5790 | 0.160 |
Why?
|
Retinoblastoma Protein | 1 | 2022 | 672 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11458 | 0.160 |
Why?
|
Triazoles | 1 | 2024 | 903 | 0.160 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 170 | 0.150 |
Why?
|
Mandibular Neoplasms | 1 | 2019 | 130 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 118 | 0.150 |
Why?
|
Neoplasms | 7 | 2024 | 22164 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 208 | 0.150 |
Why?
|
Viral Vaccines | 1 | 2003 | 596 | 0.150 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 560 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 18 | 0.150 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5365 | 0.150 |
Why?
|
RANK Ligand | 1 | 2019 | 318 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 6 | 2018 | 4510 | 0.140 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13337 | 0.140 |
Why?
|
Papillomaviridae | 1 | 2003 | 1119 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6132 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11073 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2020 | 492 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 368 | 0.140 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1125 | 0.140 |
Why?
|
Stromal Cells | 2 | 2019 | 1330 | 0.140 |
Why?
|
Apoptosis | 7 | 2024 | 9488 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
Protein Binding | 5 | 2020 | 9352 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1250 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2510 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2016 | 2985 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2015 | 1135 | 0.130 |
Why?
|
Gene Expression Regulation | 5 | 2016 | 11902 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 181 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 82 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 1250 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.130 |
Why?
|
Fibrosis | 2 | 2019 | 2048 | 0.130 |
Why?
|
Principal Component Analysis | 2 | 2017 | 942 | 0.130 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 169 | 0.120 |
Why?
|
RNA Interference | 3 | 2019 | 2831 | 0.120 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3874 | 0.120 |
Why?
|
Oligodendroglioma | 1 | 2016 | 279 | 0.120 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 125 | 0.120 |
Why?
|
Point Mutation | 3 | 2016 | 1596 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 783 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1050 | 0.120 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1827 | 0.120 |
Why?
|
Sulfonamides | 2 | 2015 | 1975 | 0.120 |
Why?
|
Morpholines | 2 | 2015 | 581 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2017 | 938 | 0.110 |
Why?
|
Cell Lineage | 3 | 2019 | 2555 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4741 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 267 | 0.110 |
Why?
|
Mice, SCID | 2 | 2019 | 2626 | 0.110 |
Why?
|
Cell Differentiation | 9 | 2023 | 11526 | 0.110 |
Why?
|
beta Catenin | 2 | 2010 | 1040 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 694 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1021 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2022 | 2916 | 0.100 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 186 | 0.100 |
Why?
|
Carcinoma | 1 | 2024 | 2330 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2875 | 0.100 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2013 | 269 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2298 | 0.100 |
Why?
|
RNA, Messenger | 7 | 2018 | 12796 | 0.100 |
Why?
|
Lung | 2 | 2021 | 9995 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2022 | 5789 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 575 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1014 | 0.100 |
Why?
|
Antigen Presentation | 3 | 2002 | 1253 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3639 | 0.100 |
Why?
|
Serum Albumin | 1 | 2015 | 675 | 0.100 |
Why?
|
Female | 35 | 2024 | 392581 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2019 | 0.090 |
Why?
|
DNA, Satellite | 1 | 2011 | 67 | 0.090 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 150 | 0.090 |
Why?
|
Male | 28 | 2021 | 360736 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8179 | 0.090 |
Why?
|
Introns | 1 | 2013 | 981 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2016 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 611 | 0.090 |
Why?
|
Autoantigens | 1 | 2015 | 892 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1649 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1069 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2013 | 5665 | 0.090 |
Why?
|
Trans-Activators | 2 | 2022 | 2856 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1801 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1079 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1726 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 314 | 0.080 |
Why?
|
Meningioma | 1 | 2018 | 1218 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2113 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3602 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.080 |
Why?
|
Genomics | 3 | 2019 | 5820 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1393 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2013 | 1494 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 552 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1248 | 0.080 |
Why?
|
Membrane Proteins | 5 | 2015 | 7856 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 605 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2416 | 0.080 |
Why?
|
Oncogenes | 3 | 2022 | 1222 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 940 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2002 | 584 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6935 | 0.080 |
Why?
|
Signal Transduction | 6 | 2024 | 23441 | 0.080 |
Why?
|
Mice, Nude | 5 | 2013 | 3614 | 0.080 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 750 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2057 | 0.070 |
Why?
|
Binding Sites | 3 | 2023 | 6055 | 0.070 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1387 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 789 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 946 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.070 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3447 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2538 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12450 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 247 | 0.070 |
Why?
|
Transfection | 2 | 2019 | 5775 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2019 | 11118 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2018 | 18964 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1725 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2638 | 0.070 |
Why?
|
DNA Methylation | 3 | 2017 | 4391 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2019 | 4278 | 0.070 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.070 |
Why?
|
Glycoproteins | 2 | 2016 | 2208 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13637 | 0.070 |
Why?
|
Cell Line | 3 | 2013 | 15605 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1668 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2002 | 2746 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1459 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1651 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18247 | 0.060 |
Why?
|
Biopsy | 4 | 2020 | 6766 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2160 | 0.060 |
Why?
|
Cell Proliferation | 5 | 2020 | 10441 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2023 | 21012 | 0.060 |
Why?
|
RNA | 3 | 2022 | 2723 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4414 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3030 | 0.060 |
Why?
|
Child | 10 | 2023 | 80162 | 0.060 |
Why?
|
Child, Preschool | 5 | 2019 | 42254 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 102 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5302 | 0.060 |
Why?
|
Adult | 13 | 2021 | 221148 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 851 | 0.060 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2016 | 84 | 0.060 |
Why?
|
Protein Stability | 2 | 2020 | 578 | 0.060 |
Why?
|
Middle Aged | 15 | 2021 | 220826 | 0.060 |
Why?
|
Fatty Acids | 1 | 2012 | 1808 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9031 | 0.060 |
Why?
|
SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
Glioblastoma | 3 | 2014 | 3482 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1610 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2423 | 0.060 |
Why?
|
Aged | 12 | 2021 | 169235 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2892 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3522 | 0.050 |
Why?
|
Organoids | 2 | 2020 | 740 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 507 | 0.050 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 130 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2014 | 4936 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4021 | 0.050 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2006 | 764 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4764 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2006 | 570 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3612 | 0.050 |
Why?
|
E2F Transcription Factors | 1 | 2022 | 269 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3455 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15262 | 0.050 |
Why?
|
Cell Nucleolus | 1 | 2022 | 156 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 29620 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5819 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
Epigenomics | 2 | 2020 | 942 | 0.050 |
Why?
|
Acetylation | 2 | 2016 | 1055 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2022 | 227 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7584 | 0.050 |
Why?
|
Mutation | 6 | 2023 | 30045 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 321 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 366 | 0.050 |
Why?
|
Intestines | 2 | 2022 | 1909 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9535 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13449 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 149 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2024 | 1743 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5305 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 698 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2871 | 0.040 |
Why?
|
Heterozygote | 1 | 2007 | 2803 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2321 | 0.040 |
Why?
|
Heart Failure | 2 | 2015 | 11674 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4575 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17644 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 35 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9277 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2020 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 2 | 2016 | 1062 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 67 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5727 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Alleles | 2 | 2007 | 6922 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 396 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 582 | 0.040 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 73 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 834 | 0.040 |
Why?
|
Histones | 2 | 2020 | 2580 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58956 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2022 | 539 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2054 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2002 | 4575 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2230 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 329 | 0.040 |
Why?
|
Immunoblotting | 2 | 2012 | 1647 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 836 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3812 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 612 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 568 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2021 | 2448 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 855 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2014 | 1745 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2224 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22163 | 0.040 |
Why?
|
Antigens | 1 | 2002 | 1446 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1037 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3271 | 0.040 |
Why?
|
Mice, Knockout | 5 | 2016 | 14409 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2010 | 671 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.040 |
Why?
|
Autopsy | 1 | 2020 | 1007 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.030 |
Why?
|
Liposomes | 1 | 2000 | 783 | 0.030 |
Why?
|
Th2 Cells | 1 | 2022 | 1058 | 0.030 |
Why?
|
Mucin-2 | 1 | 2016 | 50 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3667 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10762 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1659 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 597 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2002 | 2821 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 719 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2016 | 95 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1355 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5768 | 0.030 |
Why?
|
Genome, Human | 2 | 2010 | 4425 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 774 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 261 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 174 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2488 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1115 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 129 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1340 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 227 | 0.030 |
Why?
|
Antigens, CD | 2 | 2002 | 4001 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1966 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 871 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3702 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 997 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 80 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 361 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2016 | 535 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 2918 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1997 | 439 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 465 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11740 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2523 | 0.030 |
Why?
|
Steroids | 1 | 2019 | 929 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2300 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1176 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3423 | 0.030 |
Why?
|
England | 1 | 2015 | 527 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 191 | 0.030 |
Why?
|
Genes, ras | 1 | 2016 | 654 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 745 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4549 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 59207 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 731 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13502 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4370 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1529 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 256 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6374 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1664 | 0.020 |
Why?
|
Cerebellum | 1 | 2019 | 1500 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2013 | 410 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12970 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 918 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3330 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 88313 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.020 |
Why?
|
Phenotype | 4 | 2019 | 16606 | 0.020 |
Why?
|
Computational Biology | 1 | 2003 | 3517 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2002 | 293 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 175 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2065 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 955 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 384 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2001 | 5490 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1118 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1750 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20093 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 80582 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 508 | 0.020 |
Why?
|
Prostate | 1 | 2018 | 1770 | 0.020 |
Why?
|
Ovalbumin | 2 | 2002 | 677 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 803 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4124 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3057 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2677 | 0.020 |
Why?
|
Proteomics | 1 | 2003 | 3845 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1271 | 0.020 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 223 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8320 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 888 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 933 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2395 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6581 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2811 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 330 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2201 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1806 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4140 | 0.020 |
Why?
|
Calcium Channels | 1 | 2012 | 620 | 0.020 |
Why?
|
Heterochromatin | 1 | 2011 | 293 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 796 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1053 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 714 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5868 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1361 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1824 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 579 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2820 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4921 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2203 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 878 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5036 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 323 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 352 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7392 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3779 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36205 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 637 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1405 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2851 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2010 | 906 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39117 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4650 | 0.020 |
Why?
|
Fetus | 1 | 2013 | 1864 | 0.020 |
Why?
|
Podocytes | 1 | 2010 | 405 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4172 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1306 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54415 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6814 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 22168 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 6032 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1743 | 0.020 |
Why?
|
Karyotyping | 1 | 2007 | 1171 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
Astrocytes | 1 | 2013 | 1345 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 791 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1093 | 0.020 |
Why?
|
Retroviridae | 1 | 2007 | 850 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2013 | 2908 | 0.010 |
Why?
|
Genes, Duplicate | 1 | 2004 | 30 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5335 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2001 | 10194 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 2003 | 18 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4779 | 0.010 |
Why?
|
Software Validation | 1 | 2003 | 59 | 0.010 |
Why?
|
MEDLINE | 1 | 2003 | 119 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1263 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10766 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9330 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41446 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5203 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2011 | 2863 | 0.010 |
Why?
|
Gene Amplification | 1 | 2006 | 1088 | 0.010 |
Why?
|
Muramidase | 1 | 2001 | 169 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2015 | 3234 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2000 | 46 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2557 | 0.010 |
Why?
|
Drug Stability | 1 | 2000 | 291 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2002 | 3466 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3816 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9462 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1218 | 0.010 |
Why?
|
United States | 2 | 2020 | 72339 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64651 | 0.010 |
Why?
|
Drug Compounding | 1 | 2000 | 246 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23990 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23742 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3612 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4110 | 0.010 |
Why?
|
Zebrafish | 1 | 2010 | 3007 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 958 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2000 | 819 | 0.010 |
Why?
|
Disease | 1 | 2003 | 672 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17912 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15838 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1742 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2003 | 2706 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2295 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4876 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 2611 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2645 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2691 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 801 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2265 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 1903 | 0.010 |
Why?
|
Thymus Gland | 1 | 1997 | 1243 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36423 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12688 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2000 | 2225 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3755 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 26212 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5091 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9179 | 0.000 |
Why?
|
Hypertension | 1 | 2003 | 8542 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 14026 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9469 | 0.000 |
Why?
|